The added cost of rapid diagnostic testing and active antimicrobial stewardship: Is it worth it?

Journal of Clinical Microbiology

Volumn 55, Issue 1, 2017, Pages 20-23

  TeKippe, Erin McElvania ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BIOCHEMISTRY; BLOODSTREAM INFECTION; COST BENEFIT ANALYSIS; COST CONTROL; CURRENT PROCEDURAL TERMINOLOGY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORBIDITY; MORTALITY; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; COST; DIAGNOSTIC TEST; ECONOMICS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; ANTIMICROBIAL STEWARDSHIP;

ANTIINFECTIVE AGENT;

ANTI-INFECTIVE AGENTS; COSTS AND COST ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85027445799     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bizzini A, Greub G. 2010. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 16:1614-1619. https://doi.org/10.1111/j.1469-0691.2010.03311.x.
2. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49:543-551. https://doi.org/10.1086/600885.
3. van Veen SQ, Claas EC, Kuijper EJ. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 48:900-907. https://doi.org/10.1128/JCM.02071-09.
4. Tan K, Ellis B, Lee R, Stamper P, Zhang S, Carroll K. 2012. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and costeffectiveness. J Clin Microbiol 50:3301-3308. https://doi.org/10.1128/JCM.01405-12.
5. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 49:1614-1616. https://doi.org/10.1128/JCM.02381-10.
6. Seng P, Abat C, Rolain JM, Colson P, Lagier J-C, Gouriet F, Fournier PE, Drancourt M, La Scola B, Raoult D. 2013. Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of MALDI-TOF mass spectrometry. J Clin Microbiol 51:2182-2194. https://doi.org/10.1128/JCM.00492-13.
7. Centers for Disease Control and Prevention. 2016. Core elements of hospital antibiotic stewardship programs. http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html. Accessed 21 October 2016.
8. Center for Medicare and Medicaid Services. 2016. CMS issues proposed rule that prohibits discrimination, reduces hospital-acquired conditions, and promotes antibiotic stewardship in hospitals. https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-sheets-items/2016-06-13.html. Accessed 21 October 2016.
9. Doern GV. 2014. The value of outcomes data in the practice of clinical microbiology. J Clin Microbiol 52:1314-1316. https://doi.org/10.1128/JCM.00712-14.
10. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM. 2014. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 69:216-225. https://doi.org/10.1016/j.jinf.2014.05.005.
11. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM. 2013. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:1247-1254. https://doi.org/10.5858/arpa.2012-0651-OA.
12. Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J, Patel T, Newton DW. 2014. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52:2849-2854. https://doi.org/10.1128/JCM.00682-14.
13. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 29 July 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis https://doi.org/10.1093/cid/cit498.
14. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596. https://doi.org/10.1097/01.CCM.0000217961.75225.E9.
15. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155. https://doi.org/10.1378/chest.118.1.146.
16. Patel TS, Kaakeh R, Nagel JL, Newton DW, Stevenson JG. 2017. Cost analysis of implementing matrix-assisted laser desorption ionization-time of flight mass spectrometry plus real-time antimicrobial stewardship intervention for bloodstream infections. J Clin Microbiol 55:60-67. https://doi.org/10.1128/JCM.01452-16.
17. Vardakas KZ, Anifantaki FI, Trigkidis KK, Falagas ME. 2015. Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes. Eur J Clin Microbiol Infect Dis 34:2149-2160. https://doi.org/10.1007/s10096-015-2466-y.
18. Doern CD. 2016. The confounding role of antimicrobial stewardship programs in understanding the impact of technology on patient care. J Clin Microbiol 54:2420-2423. https://doi.org/10.1128/JCM.01484-16.
19. MacVane SH, Nolte FS. 2016. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54:2455-2463. https://doi.org/10.1128/JCM.00996-16.